An Eli Lilly & Co. Zepbound injection pen. Photographer: Shelby Knowles/Bloomberg.
Share this article
Corporate
Score 75
Bearish
Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts
Mar 17, 2026 13:59 UTC
LLY, XBI, SPY
Short term
Related Articles
Score 35
Is a Reverse Stock Split Inevitable for Beyond Meat?
Mar 17, 16:20
Score 25
Bullish
Could Nebius Stock Be a 10X Investment?
Mar 17, 16:20
Score 85
Bullish
Uber’s stock powers higher as Nvidia robotaxi deal helps avert ‘doomsday’ scenario
Mar 17, 16:20
Score 45
Bullish
From $49 to $110: Why Piper Sandler Thinks CRSP Can More Than Double From Here
Mar 17, 16:16
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.